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Abstract
Background: Regulator of G-protein signaling (RGS) proteins have been well-described as accelerators of Ga-mediated GTP
hydrolysis (‘‘GTPase-accelerating proteins’’ or GAPs). However, RGS proteins with complex domain architectures are now
known to regulate much more than Ga GTPase activity. RGS14 contains tandem Ras-binding domains that have been
reported to bind to Rap- but not Ras GTPases in vitro, leading to the suggestion that RGS14 is a Rap-specific effector.
However, more recent data from mammals and Drosophila imply that, in vivo, RGS14 may instead be an effector of Ras.
Methodology/Principal Findings: Full-length and truncated forms of purified RGS14 protein were found to bind
indiscriminately in vitro to both Rap- and Ras-family GTPases, consistent with prior literature reports. In stark contrast,
however, we found that in a cellular context RGS14 selectively binds to activated H-Ras and not to Rap isoforms. Co-
transfection / co-immunoprecipitation experiments demonstrated the ability of full-length RGS14 to assemble a
multiprotein complex with components of the ERK MAPK pathway in a manner dependent on activated H-Ras. Small
interfering RNA-mediated knockdown of RGS14 inhibited both nerve growth factor- and basic fibrobast growth factor-
mediated neuronal differentiation of PC12 cells, a process which is known to be dependent on Ras-ERK signaling.
Conclusions/Significance: In cells, RGS14 facilitates the formation of a selective Ras?GTP-Raf-MEK-ERK multiprotein complex
to promote sustained ERK activation and regulate H-Ras-dependent neuritogenesis. This cellular function for RGS14 is
similar but distinct from that recently described for its closely-related paralogue, RGS12, which shares the tandem Ras-
binding domain architecture with RGS14.
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Introduction
Many extracellular signaling molecules exert their cellular
effects through activation of G protein-coupled receptors (GPCRs)
[1–3]. GPCRs are seven transmembrane spanning proteins
coupled to a membrane-associated heterotrimeric complex that
is comprised of a GTP-hydrolyzing Ga subunit and a Gbc dimeric
partner [1,2]. Agonist-bound GPCRs catalyze the release of GDP,
and subsequent binding of GTP, by the Ga subunit [1,2]. On
binding GTP, conformational changes within the three ‘switch’
regions of Ga facilitate the release of the Gbc dimer. Ga?GTP and
Gbc subunits regulate the activity of target effector proteins such
as adenylyl cyclases, phospholipase C isoforms, ion channels, and
phosphodiesterases, which in turn regulate multiple downstream
signaling cascades that initiate key biological processes such as
development, vision, olfaction, cardiac contractility, and neuro-
transmission [1–3]. The intrinsic GTP hydrolysis (GTPase) activity
of Ga resets the cycle by forming Ga?GDP – a nucleotide state
with low affinity for effectors but high affinity for Gbc.
Reassociation of Ga?GDP with Gbc reforms the inactive, GDP-
bound heterotrimer which completes the cycle [1,2]. Thus, the
duration of G-protein signaling through effectors is thought to be
controlled by the lifetime of the Ga subunit in its GTP-bound
form [2,4]. The lifetime of Ga?GTP is modulated by RGS
(regulators of G-protein signaling) domain-containing proteins [4].
The RGS domain is a ,120 amino-acid nine-alpha helical bundle
[5,6] that contacts Ga subunits and thereby dramatically
accelerates GTPase activity [7,8]. Many RGS proteins catalyze
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or modulate GPCR-initiated signaling in vivo [4,5,8]; accordingly,
RGS proteins are considered key desensitizers of heterotrimeric G-
protein signaling pathways [4,8].
It has become apparent that the signature RGS domain is a
modular protein fold found inmultiple biological contexts [4,8]. The
identification of multidomain RGS proteins has led to a new
appreciationofthese molecules asbeing morethan justGAPsforGa
subunits [4,8,9]. RGS14 is an RGS protein with multiple signaling
regulatory elements, as it contains an RGS domain, tandem RBDs
(Ras-binding domains), and a GoLoco motif [10,11]. In addition to
the RGS domain of RGS14 acting as a GAP for Gai/o subunits [11–
13], the GoLoco motif of RGS14 functions as a guanine nucleotide
dissociation inhibitor (GDI) for Gai1/i3 subunits [14,15]. Beyond
regulation of heterotrimeric Ga signaling, RGS14 is also reported to
bind to activated monomeric G-proteins. An early yeast two-hybrid
analysis of interactions between RGS14 and Ras-family GTPases
reported a selective interaction between RGS14 and activated
Rap1B, but not H-Ras [11]; in vitro experiments have also shown
RGS14 binding in a nucleotide-dependent manner to the small
GTPases Rap1 and Rap2 but not Ras [11,16–18]. Based on these
results, it has been suggested that RGS14 may be a direct effector of
Rap in vivo. However, subsequent to this initial identification of Rap
(andnotRas)asasmallGTPasebindingtargetofRGS14,additional
studies have suggested that Ras may also bind to RGS14. Kiel et al.
[16] found that RGS14 binds preferentially to both activated Rap1B
and activated H-Ras in vitro, and that this interaction is mediated by
the first RBD of RGS14. Similarly, Formstecher et al. [19] identified
Loco (the Drosophila RGS12/14 orthologue) in a screen for binding
partners of activated Rap1, Rap2, and Ras1. Finally, we have
recently discovered that RGS12, the mammalian paralogue of
RGS14, binds specifically to activated H-Ras in cells [20].
Collectively, these results suggest that RGS14 may bind to Rap
and/or Ras GTPases. In addition to binding activated H-Ras, we
found that RGS12 promotes a differentiated phenotype in both
PC12 cells and embryonic DRG neurons by organizing a Ras, Raf,
MEK,and ERKsignaltransduction complex[20].The requirement
for RGS12 in nerve growth factor (NGF)-induced neuritogenesis of
PC12 cells and axonal growth of embryonic DRG neurons suggests
that the related protein RGS14 may play a similar role in
coordinating Ras-dependent signals that are required for promoting
and/or maintaining cellular differentiation [20].
Our aim with these present studies was to resolve the discordant
ideas regarding the monomeric G-protein selectivity of RGS14, as
well as to establish a cellular role for such RGS14/monomeric G-
protein interaction(s). Here, we demonstrate that full-length and
truncated forms of RGS14 bind promiscuously to Rap and Ras
GTPases in vitro, consistent with earlier reports. In cells, however,
RGS14 selectively binds to activated H-Ras and not Rap nor most
other Ras family isoforms. Additionally, RGS14 facilitates the
formation of a Raf/MEK/ERK multiprotein complex that is
dependent on activated H-Ras. Furthermore, small interfering RNA
(siRNA)-mediated downregulation of RGS14 inhibits both NGF-
and basic fibrobast growth factor (bFGF)-mediated neuritogenesis of
PC12 cells, both processes known to require Ras-ERK signaling.
These results suggest that RGS14 may regulate neuronal differen-
tiation by the selective organization of a Ras?GTP-dependent Raf,
MEK, and ERK signal transduction complex in vivo.
Materials and Methods
Materials
2.5S mouse NGF was from Roche (Indianapolis, IN). Human
basic FGF was from Sigma (St. Louis, MO). Antibodies: Anti-b-
actin (AC-74) and anti-FLAG M2 (Sigma), anti-ERK1/2 and anti-
phospho-ERK1/2(T202, Y204) (Cell Signaling Technologies;
Danvers, MA), anti-HA-HRP 3F10 and anti-myc 9E10 (Roche),
anti-myc-HRP 4A6 (Millipore, Billerica, MA), anti-rabbit IgG
HRP and anti-mouse IgG HRP (GE Healthcare; Piscataway, NJ),
and anti-Rap2 (BD Biosciences, San Jose, CA). All siRNAs were
from Dharmacon (Lafayette, CO). siRNA sequences: rat RGS14
siGENOME SMARTpool (sense strand sequences: duplex 1, 59-
GUACGGAUCUCUGCUAAGC-39; duplex 2, 59-GAAAGU-
CACUGCCGCUCGG-39; duplex 3, 5-GGGAAGUACUGCU-
GCGUGU-39; duplex 4, 59-CCGCAAGUCCUUUCGUAGA-
39). Rat RGS12(duplex 2) siRNA and the control ‘non-specific’
siRNA are described in [20]. Unless elsewhere specified, all
additional reagents were of the highest quality obtainable from
Sigma or Fisher (Pittsburgh, PA).
Molecular biology
All DNA constructs were created using standard methods or
obtained for these studies as described in Table S1. Site-directed
mutagenesis was performed using the QuikChange system
(Stratagene, La Jolla, CA). All DNA constructs were verified by
DNA sequencing (Agencourt, Beverly, MA).
Cell culture and transfection
HEK293T and PC12 cells were cultured and transfected as
described previously [20]. In PC12 experiments, pBabe-puro
retrovirus expression vectors encoding constitutively-actived B-
Raf(V600E) and H-Ras(G12V) were co-transfected with siRNA
using LipofectAMINE 2000 (Invitrogen, Carlsbad, CA), essentially
as described [20]. For co-transfections, 300 ng DNA and 150 pmol
siRNA were used in a final volume of 1 ml, in 12-well plates.
Neurite length was quantifiedafter 3 days(B-Raf) or 4 days (H-Ras).
We were unable to obtain an antibody capable of specifically
detecting endogenous levels of murine RGS14, and thus unable to
directly test for RGS14 protein knockdown in PC12 cells. To
obviate this problem,we initially tested the specificity and efficacy of
siRNA duplexes using HEK293T cells. HEK293T cells were plated
in antibiotic-free DMEM at 165,000 cells per well in a total volume
of 1 ml per well of a 12-well plate. The following day, cells were
transfected with epitope-tagged RGS14 expression constructs:
20 ng myc-tagged rat RGS14 were transfected using FuGENE-6
(Roche) as described [20,21]. pcDNA3.1 was used to balance DNA
amounts to a total of 1.5 mg per well. Five hours after transfection,
medium was removed and cells were equilibrated in 1 ml OPTI-
MEM-I (Invitrogen) for one hour. Subsequently, cells were
transfected with siRNA duplexes using LipofectAMINE 2000, as
described [20]. Five hours after siRNA transfection, the medium
was changed to 2 ml of antibiotic-free medium per well.
Quantitative PCR
For qRT-PCR experiments that validated the specificity and
efficacy of RNAi-mediated knockdown, PC12 were transfected
with siRNA duplexes as described above. 48 hours post transfec-
tion, cells were washed once with PBS and then scraped and
resuspended in 500 ml of PBS. Total RNA extraction and
subsequent RT-PCR was performed exactly as previously
described [22] using gene-specific primers and 6-carboxyfluor-
escein (FAM) and 6-carboxytetramethylrhodamine (TAMRA)
dual labeled probes. Primer sequences: Rat b-actin: forward, 59-
TGCCTGACGGTCAGGTCA-39; reverse, 59-CAGGAAGGA-
AGGCTGGAAG-39; probe 59-FAM-CACTATCGGCAATGA-
GCGGTTCCG-TAMRA-39; Rat RGS12: forward, 59-CATGTC
CCTGCACATGACAA-39; reverse, 59-TGGCTT TGCTGCA-
CAGGAAT-39; probe, 59-FAM-AAAATCTCCCGGGCCCTG-
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GACATTAAGGTCTACC; reverse, 59-ACGGTG CAGTCCT-
GATCCA-39; probe, 59-FAM-CAG GGCCTTCTGTTCTT-
TGCCCA-TAMRA-39. The number of cycles until threshold
(Ct) was determined using an ABI Prism 7700 Sequence Detector
System (Applied Biosystems, Foster City, CA). To normalize for
variation in the total number of cells and the efficiency of the
mRNA extraction, the Ct value for b-actin Ct(b-actin) was
subtracted from Ct values for RGS12 Ct(RGS12) and RGS14
Ct(RGS14). The change in RGS12 and RGS14 expression was
then determined relative to cells treated with non-specific siRNA
using the 2
2(DDCt) method [23]. For example, RGS14 expression
levels relative to control-treated (non-specific siRNA) samples were
determined using the following equation:
RGS14 ½  ~100|2{ DCt RGS14:siRNA ðÞ {DCt NS:siRNA ðÞ ðÞ
where
DCt(RGS14:siRNA)=Ct(RGS14)2Ct(b-actin) and
DCt(NS:siRNA)=Ct(NS)2Ct(b-actin). All experiments
were performed in triplicate.
Neurite outgrowth
PC12 neurite outgrowth was quantified essentially as described
[20]. For co-transfection experiments involving siRNA knockdown
along with activated H-Ras/B-Raf expression, percentages of cells
containing neurites longer than one cell body were also
determined. Bright-field photomicrographs of PC12 cells were
obtained as described [20]. To enhance the visibility of neurites,
micrographs were processed for publication using Adobe Photo-
shop (v7.0.1); the following commands were used sequentially:
greyscale, autocontrast, autolevel, curves (50% input, 25% output).
Bimolecular fluorescence complementation
HEK 293T cells were seeded at 200,000 cells per well in 6-well
dish. Cells were transfected with a total of 1 mgo fD N Au s i n g
FuGENE-6 (3 ml/mg of DNA). Empty pcDNA3.1 vector DNA was
used to maintain a constant amount of total DNA per well. Forty-
eight hours post-transfection, epifluorescence images were acquired
using an Olympus I670 fluorescence microscope with a Q-Fire CCD
camera (Olympus, USA). All digital images were acquired using
14.1 sec exposures at 206magnification and imported into Photo-
shop. Digital images were saved as ‘‘portable network graphics’’
(PNG) files and imported into MATLAB 2007a (The MathWorks,
Inc. Natick, MA). Pixels with greater than 40 units of intensity in the
green channel were considered to be fluorescent. The percent of
fluorescent pixels for each experiment was then quantified. All
experiments were repeated three times. Control experiments were
performed to demonstrate the specificity of fluorescence complemen-
tation: e.g.,Y F P N alone was unable to complement YFPC-RGS14 and
YFPC alone was unable to complement YFPN-H-Ras(G12S).
Western blotting
Protein/cell lysate electrophoresis and immunoblotting was
performed as described [20]. Images were scanned using a
Perfection 1200/GT-7600 scanner (Epson; Long Beach, CA).
Quantification of immunoblots was performed using the Scion
Image measure function (Scion Corp, Frederick, MD).
Immunoprecipitation
Immunoprecipitation experiments were conducted essentially as
described [20], with the minor modification that all lysis and wash
buffers contained 20 mM MgCl2. Immunoprecipitations were
carried out by incubation of cell lysates with antibodies overnight
at 4uC, and immune complex precipitation was achieved by
incubation with 40 ml of protein A/G agarose (Santa Cruz) for one
hour before washing and elution. All washing and elution steps
were performed chromatographically using micro Bio-Spin
columns (BioRad, Hercules, CA), as described [24]. For some
experiments, pre-clearing of lysates was used to reduce non-
specific binding. Pre-clearing was performed by incubating lysates
at 4uC with 50 ml protein A/G agarose for 2 h. Agarose beads
were removed from lysates using micro Bio-Spin columns.
GST co-precipitations
Glutathione agarose was prepared by resuspension of dry beads
in excess lysis buffer (20 mM TRIS/HCl pH 7.5, 100 mM NaCl,
20 mM MgCl2, 1 mM EGTA, 1% (v/v) Triton X-100, and
Complete Mini protease inhibitors (Roche)). Beads were swollen
for 10 min and then washed three times by brief centrifugation,
and prepared for use as a 50% (v/v) slurry. HEK293T cells were
transfected with expression plasmids for small GTPases (1500 ng
DNA/well of a 6 well dish) as described [20,21]. Cells were lysed
in 750 ml per well of lysis buffer; generally one well per
experimental condition was sufficient. Lysates were prepared as
described [20], and then pre-cleared for 2–4 h at 4uC with 100 ml
per sample of glutathione agarose beads. Beads were removed
from lysates using micro Bio-Spin columns. 500 pmol GST-fusion
protein was added per lysate sample, and aliquots of this mixture
were taken as ‘Loading Control’ samples for SDS-PAGE. Lysate/
GST-fusion protein mixtures were then incubated overnight at
4uC, with gentle agitation. Subsequently, GST-fusion proteins and
bound GTPases were precipitated with 40 ml of glutathione
agarose by incubation at 4uC, for 1 h, with gentle agitation. Beads
were applied to micro Bio-Spin columns and washed by gravity
flow with 461 ml lysis buffer, followed by a final brief
centrifugation (16,3006g, 30 s). Protein was eluted with 60 ml
Laemmli buffer and centrifugation (16,3006g, 30 s).
Protein purification
The bacterial expression vectors pNIC-SGC(RGS14
(RBD1.RBD2)) or pPROEXHTb(H-Ras) were separately ex-
pressed in BL21(DE3) E. coli, essentially as described [25]. One
liter cultures of terrific broth were grown at 37uC until an
OD600 nm of 1 was reached. Protein was induced with 0.5 mM
isopropyl b-D-thiogalactoside for 12 h at 22uC. Cells were
harvested by centrifugation at 90006g for 20 min and resus-
pended in lysis buffer (50 mM HEPES, pH 7.5, 300 mM NaCl,
5% (v/v) glycerol and 10 mM imidazole) and frozen at 280uC
until further use. Cell pellets containing H-Ras were resuspended
in the above buffer supplemented with 2 mM MgCl2. Frozen cell
pellets were thawed in the presence of one EDTA-free
Complete
TM protease inhibitor tablet per liter (Roche) and then
were lysed using an Emulsiflex C5 high pressure homogenizer
(Avestin; Ottawa, Canada). Poly(ethyleneimine) was then added to
a final concentration of 0.15% (v/v) and insoluble debris was
removed by centrifugation for 45 min at 15000 rpm using a JA-17
rotor (Beckman Coulter, Fullerton, CA). Protein was extracted
from clarified supernatant by affinity-tag purification using Ni-
NTA (Ni
2+-nitrilotriacetate) resin (Qiagen, Valencia, CA). H-Ras
purification buffers were supplemented with 2 mM MgCl2.
Supernatant was passed over Ni-NTA resin, which was then
washed with 30 column volumes of lysis buffer and 5 column
volumes of wash buffer (50 mM HEPES, pH 7.5, 300 mM NaCl,
5% (v/v) glycerol and 25 mM imidazole). Protein was eluted from
the resin with 5 column volumes of elution buffer (50 mM
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imidazole). Eluted protein was purified further by gel filtration
chromatography using a Sephadex S200 16/60 column (GE
Healthcare). RGS14(RBD1.RBD2) was subject to gel filtration
using 50 mM HEPES, pH 7.5, 300 mM NaCl, and 0.5 mM
Tris(2-carboxyethyl)phosphine hydrochloride. H-Ras was treated
for 12 h with 50 U of calf intestinal phosphatase, 10 mM EDTA,
TEV protease and 1 mM GPPNHP at 4uC and then subjected to
gel filtration using 50 mM HEPES pH 7.5, 150 mM NaCl, 2 mM
MgCl2, 0.5 mM TCEP. Proteins were concentrated using 10 kDa
cut-off Amicon ultra filters (Millipore, Burlington, MA). GST-
RGS14-His6 was purified as described [26]; all other GST-fusion
proteins were purified as described [24].
Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) measurements were
carried out at 20uC using a VP-ITC MicroCalorimeter (MicroCal;
Northampton, MA). Guanine nucleotide-loaded H-Ras and
RGS14(RBD1.RBD2) were each in a solution of 20 mM HEPES,
pH 7.5, 150 mM NaCl, 1 mM MgCl2 and 0.5 mM TCEP, which
was degassed in a ThermoVac apparatus (MicroCal). ITC
experiments were performed by stepwise titration of
RGS14(RBD1.RBD2) (300 mM) into an adiabatic cell containing
H-Ras (20 mM), and the heat energy change accompanying the
reaction was detected upon each injection by comparison with a
reference cell. Protein solution was placed in the 1.4 ml
calorimeter cell and stirred to ensure rapid mixing, and 10 ml
aliquots of the titrant were injected over 10 s with a 4 min interval
between each injection until saturation. The titrant injected into
buffer alone was used as a negative control. Heat change data was
determined by subtracting values obtained when RGS14 was
titrated into buffer alone. Subsequently, data was integrated and
plotted against the molar ratio of H-Ras/RGS14 and analyzed as
a non-linear least-squares fit. Data were analyzed using a single
binding site model with the ORIGIN software package supplied
by MicroCal.
Yeast two-hybrid assay
Yeast two-hybrid assays were performed essentially as described
[27] using PJ69-4A S. cerevisiae [28]. ‘‘Bait’’ constructs in pGBT9
encoded the H-Ras and Rap1B GTPases fused to the Gal4p DNA
binding domain, as described [29,30]. ‘‘Prey’’ constructs in
pACTII [31] encoded the Gal4p activation domain fused to the
isolated RBDs of human Raf-1 or rat RGS14.
Statistics
Graphical and statistical analysis was performed using Prism 4.0
(GraphPad, San Diego, CA). All data presented are representative
of three or more independent experiments.
Results
RGS14 binds promiscuously in vitro to Ras and Rap
isoforms
RGS14 contains two putative RBDs in tandem, and has
previously been demonstrated to interact preferentially with the
GTP-bound forms of Rap1 and Rap2 but not Ras [11,17,18].
However, one group has used ITC to show that the isolated
tandem RBDs of RGS14 have micromolar binding affinities for
both recombinant H-Ras and Rap1B [16]. To determine the
selectivity of RGS14 for Ras-family GTPases in vitro and to
examine the contribution of each individual RBD to this
interaction, we expressed the wild-type and activated forms of
H-Ras, Rap2A, and Rap2B in HEK 293T cells, and measured the
RGS14/GTPase interaction using GST pull-down assays. Purified
recombinant RGS14 (both full-length and truncated versions)
interacted selectively with activated (and not wild-type) H-Ras,
and this interaction was dependent upon the presence of the first
RBD of RGS14 (Figure 1A; e.g., compare GST-RGS14.RBD1 vs
GST-RGS14.RBD2). We next examined the ability of GST-
RGS14 fusion proteins to interact with wild-type and activated
Rap2A and Rap2B. Interactions were observed with both Rap2A
and Rap2B, and this binding appeared to be mediated by the first
RBD in the tandem array; however, in contrast to the interaction
with H-Ras (Figure 1A), the interaction was independent of the
nucleotide state of Rap2A/2B (Figure 1B and 1C). (Note that
endogenous RapGEF activity in HEK 293T cells could result in a
significant amount of wild type Rap protein being GTP-bound.)
As other Ras family members can interact with RBD-containing
proteins [32,33], we conducted a broader analysis of RGS14
selectivity for Ras family GTPases, initially in this in vitro setting
with recombinant RGS14 protein. GST-RGS14(RBD1.RBD2)
fusion protein interacted with activated versions of other Ras
isoforms (K- and N-Ras) and R-Ras proteins (R-Ras1 and R-
Ras3/M-Ras) in GST pull-down assays, suggesting that RGS14 is
also capable of binding multiple Ras and R-Ras isoforms in vitro
(Figure 2). Similarly, we examined the ability of RGS14 to interact
with additional Rap isoforms. GST-RGS14(RBD1.RBD2) co-
precipitated with activated Rap1A and Rap1B (Figure 2).
Isothermal titration calorimetry was then employed to demon-
strate a direct in vitro protein-protein interaction and to measure
the affinity of GDP or GPPNHP loaded H-Ras for
RGS14(RBD1.RBD2). H-Ras was observed to directly interact
with RGS14(RBD1.RBD2) in a 1-to-1 stoichiometry (Table 1 and
Figure S1). The affinity between GTP-analogue bound (activated)
H-Ras and RGS14(RBD1.RBD2) was significantly higher (KD
,10 mM) than that of GDP-bound (inactive) H-Ras and
RGS14(RBD1.RBD2) (KD.200 mM) (Table 1).
RGS14 preferentially interacts with activated H-Ras in
cells
We examined the capacity of RGS14 to interact with Ras
proteins in mammalian cell co-immunoprecipitation (co-IP) assays.
Whereas the in vitro GST pull-down assays revealed promiscuous
association of full-length RGS14 (and truncated forms containing
the RBDs) with multiple different Ras isoforms (Figure 1 and
Figure 2), in cells full-length RGS14 stably associated preferentially
withactivatedH-RasoverotherRasisoforms(Figure3AandFigure
S2). We consistently observed cellular co-IP of full-length RGS14
with N-Ras(G12D), but it was of lower magnitude than binding to
H-Ras(G12V) (Figure S2). Interestingly, we did not observe cellular
co-IP between full-length RGS14 and Rap1A, Rap1B, Rap2A, nor
Rap2B (Figures 3B, 3C, and S2), suggesting that the physiological
Ras protein family target for RGS14 is H-/N-Ras, and not Rap
GTPases. We also did not observe an interaction between RGS14
and activated Ran, Rab1, Arf1, Cdc42, RalA, RhoA, Rac1, nor
Rac2 using cellular co-immunoprecipitation (Figure S2).
To examine whether full-length RGS14 and activated H-Ras
form a stable complex in cells, we used yellow fluorescent protein
(YFP) bimolecular fluorescence complementation [34,35]. DNA
encoding N-terminal (YFPN) and C-terminal fragments (YFPC)o f
YFP were cloned in-frame with target proteins. As a positive
control, we first examined the ability of YFPN-H-Ras(G12S) and
YFPC-Raf-1 to reconstitute YFP fluorescence [36]. Cellular
expression of YFPN-H-Ras(G12S) alone or YFPC-Raf-1 alone
did not produce fluorescence (Figure 4A,B,D); however, co-
expression of both proteins resulted in fluorescence complemen-
tation (Figure 4C,D). Next, we expressed YFPN-H-Ras(G12S)
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RGS14, and examined reconstitution of YFP. When expressed
individually, H-Ras(G12S) and full-length RGS14 did not produce
measurable fluorescence (Figure 4E,F,H); however, when co-
expressed, the fluorescence intensity was substantially increased
(Figure 4G,H), thus demonstrating that H-Ras and RGS14
interact in live cells. We performed a comprehensive panel of
positive and negative control experiments using various YFPN and
YFPC fusion proteins (Figure S3). These controls demonstrate the
high efficiency and specificity of YFP fluorescence complementa-
tion induced by interaction between H-Ras(G12S) and RGS14. It
is of note that YFPC-RGS14 complemented YFPN-H-Ras(G12S)
with better efficiency than did YFPC-Raf-1 (Figure 4 and Figure
S3), and with comparable efficiency to the constitutive heterodi-
mer of YFPC-Gb1 and YFPN-Gc2 (Figure S3).
RGS14 coordinates an activated H-Ras-dependent B-Raf/
MEK1/ERK1 complex
To investigate the interaction of RGS14 with multiple
components of the Ras-ERK MAPK signaling pathway, we co-
expressed RGS14 and activated Ras GTPases with Raf kinase
isoforms A-Raf, B-Raf, or Raf-1, and examined the ability of
RGS14 to bind to Ras. Full-length RGS14 does not interact with
activated R-Ras in cells (Figure 5A and Figure S2); however, both
activated H-Ras and R-Ras interact with all three Raf isoforms
(data not shown; reviewed in [37]). Activated R-Ras did not co-
immunoprecipitate with RGS14 in the absence of any of the three
Raf kinases (Figure 5A); however, in the presence of the three Raf
kinases, we observed weak interactions with R-Ras (Figure 5A)
that were comparable to the preference of R-Ras for each of the
three Raf isoforms (data not shown). In contrast, the amount of H-
Ras bound to RGS14 dramatically increased upon concomitant
expression of B-Raf and Raf-1, but not A-Raf (Figure 5A),
consistent to our previous observations of cooperative binding with
the related protein RGS12 [20]. This interaction was specific and
not an artifact of non-specific binding of the complex to beads
(Figure S4).
We also examined whether RGS14 was able to individually or
simultaneously interact with multiple ERK MAPK components in
cells. Activated H-Ras was detected in RGS14 immunoprecipi-
tates upon their co-expression (Figure 5B and also Figure 3A). In
contrast, we did not observe binary interactions between RGS14
and B-Raf, MEK1, nor ERK1, respectively (Figure 5B). However,
when RGS14 was co-expressed with activated H-Ras, B-Raf,
MEK1, and ERK1, we isolated a complex containing all five
proteins (Figure 5B).
Loss of RGS14 inhibits NGF-mediated neurite outgrowth
in PC12 cells
Stimulation of the NGF receptor, TrkA, causes terminal
differentiation, growth inhibition, and neurite formation in PC12
cells [38,39]. NGF induces rapid and sustained activation of both
Ras and ERK, and inhibition of either Ras or ERK blocks neurite
induction [40]. Thus, NGF-induced neurite formation is mediated
by Ras activation of the ERK MAPK cascade. Loss of RGS12 (a
paralogue of RGS14) leads to reduction in NGF-promoted neurite
outgrowth of PC12 cells [20]; thus, we hypothesized that RGS14
may also play an important role in neuritogenesis in PC12 cells.
Figure 1. The first Ras-binding domain of RGS14 interacts with Ras and Rap family GTPases in vitro. GST-fusion proteins of indicated full-
length or truncated RGS14 were incubated with lysates from HEK293T cells transfected with wild-type (WT) or mutationally-activated (GV) HA-tagged
H-Ras (A), Rap2A (B), or FLAG-tagged Rap2B (C). Protein complexes were precipitated with glutathione agarose, washed, and resolved by SDS-PAGE
and immunoblot (IB) (bottom panels). Experimental samples were also analyzed by immunoblot to ensure equivalent loading of GTPases (middle
panels). Precipitation of GST-fusion proteins was confirmed by SDS-PAGE and Coomassie Blue staining (top panels). Data are representative of 3 or
more independent experiments.
doi:10.1371/journal.pone.0004884.g001
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employed rat RGS14 directed-siRNA to suppress endogenous
RGS14 expression. A pool of four individual duplexes efficiently
reduced RGS14 expression at both the protein (Figure S5A) and
mRNA levels (Figure S6B). Upon their separation, all four
individual oligonucleotide duplexes also were found to efficiently
knockdown expression of RGS14 (Figure S5B and Figure S6B).
The RGS14-directed siRNAs did not silence RGS12 expression in
PC12 cells (Figure S6A), thus demonstrating the specific nature of
these reagents. RNAi-induced reduction of RGS14 expression
impaired NGF-mediated neurite formation when compared to
cells treated with control siRNA (Figure 6A); this led to a
significant reduction in the average length of NGF-promoted
neurites compared to cells transfected with non-specific siRNA
(Figure 6A). bFGF can reproduce the entire spectrum of PC12 cell
responses known to be elicited by NGF, including neurite
outgrowth [41]; thus, we also examined whether bFGF-promoted
neurite outgrowth is affected by RGS14 suppression. Suppression
of RGS14 also blocked neuritogenesis promoted by bFGF
compared to cells transfected with non-specific siRNA
(Figure 6B). To further establish the role of RGS14 in MAPK
cascade-dependent neuritogenesis, we also examined the effect of
RGS14 knockdown on PC12 neurite outgrowth stimulated by
activated mutants of H-Ras (G12V; ref. [42]) and B-Raf (V600E;
ref. [43]). Knockdown of RGS14 impaired both H-Ras- and B-
Raf-stimulated neurite formation (Figure 7).
Sustained activation of ERK by NGF and bFGF is reduced
upon knockdown of RGS14
In PC12 cells, sustained ERK activation promotes cell
differentiation, whereas a more transient duration of ERK
activation promotes growth [44–46]. Specifically, NGF, acting
through the TrkA receptor, induces both transient and prolonged
activation of ERK, with the prolonged activation required for
neuritogenesis [46,47]. To examine the effect of RGS14
knockdown on ERK activation, PC12 cells were transfected with
either non-specific siRNA or a pool of four RGS14 siRNA
duplexes (Figure 8A), and stimulated with NGF or bFGF. We
observed a reduction in the duration of ERK activation upon
RGS14 depletion when compared to cells transfected with non-
specific siRNA (Figure 8A–D). Next, we examined whether the
individual oligonucleotides were capable of reducing prolonged
ERK activation by NGF and bFGF. The duration of ERK
activation by NGF and bFGF was shortened by RGS14
knockdown (Figure 8E–H).
Discussion
Our present study has generated the following major findings: (i)
although RGS14 interacts with a wide array of Ras and Rap
isoforms in vitro, the most likely cellular target for full-length
RGS14 is activated H-Ras; (ii) the binding of activated H-Ras to
RGS14 facilitates assembly of a multiprotein complex with
components of the ERK MAPK cascade (B-Raf, MEK1, and
ERK1); (iii) loss of RGS14 expression blunts both NGF- and
bFGF-promoted neurite outgrowth of PC12 cells; and (iv) duration
of ERK activation by NGF and bFGF is shortened by RGS14
knockdown, suggesting a mechanistic explanation for impairment
of agonist-promoted neuritogenesis seen upon RGS14 depletion.
Our findings are in contrast to the original yeast two-hybrid
analysis of interactions between RGS14 and Ras-family GTPases
described by Traver et al. [11], in which interaction between
RGS14 and activated Rap1B, but not H-Ras, was observed. It is
important to note that we have independently replicated the yeast-
based data of Traver et al. [11] using (as bait) the tandem RBD C-
terminal portion of RGS14 (Figure S7). This discrepancy between
yeast two-hybrid and in vitro/cellular experiments highlights the
importance of examining protein-protein interactions under a
variety of experimental conditions.
Our demonstration that recombinant RGS14 (both full-length
and truncated species) can bind promiscuously to multiple Ras-
and Rap-family GTPases in vitro is not surprising as the switch
Figure 2. The Ras binding domains of RGS14 have promiscuous
small GTPase selectivity in vitro. GST or a GST-fusion protein of
RGS14(RBD1.RBD2) were incubated with lysates from HEK293T cells
transfected with mutationally activated Ras-family GTPases. Protein
complexes were precipitated with glutathione agarose, washed, and
resolved by SDS-PAGE and immunoblot (IB) (bottom panels). Experi-
mental samples were also analyzed by immunoblot to ensure
equivalent loading of GTPases (middle panels). Precipitation of GST-
fusion proteins was confirmed by SDS-PAGE and Coomassie Blue
staining (top panels). Data are representative of 3 or more independent
experiments.
doi:10.1371/journal.pone.0004884.g002
Table 1. Thermodynamic parameters of H-Ras binding to the tandem Ras-binding domain region of RGS14 as measured by
isothermal titration calorimetry.
Nucleotide N
a KA (M
21) DH (kcal M
21) DS (cal M
21K
21) DG (kcal M
21)
GPPNHP 1.0360.02 1.01610
567.4610
3 21.8160.04 16.6 22.13
GDP 1.0560.06 2.35610
461.9610
3 27.160.5 24.43 27.17
aThermodynamic parameters are stoichiometry (N), association constant (KA), enthalpy (DH), entropy (DS), and free energy (DG). Data are representative of 3 or more
independent experiments.
doi:10.1371/journal.pone.0004884.t001
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interactions with Ras-binding domains, are highly conserved
[48]. Yet, despite reports claiming RGS14 as a putative Rap
effector [11,18], we were unable to demonstrate interaction
between Rap and RGS14 in a mammalian cellular environment.
We are unable to explain why the yeast two-hybrid system
demonstrates that Rap1B, but not H-Ras, interacts with the
RGS14 RBD region (ref. [11] and Figure S7). This suggests that,
although it is a powerful discovery technique, the yeast two-hybrid
system should not be used in isolation to draw conclusions about in
vivo protein-protein interaction specificity. Indeed, it has been
estimated that over 50% of reported yeast two-hybrid interactions
are false positives [49].
Traver et al. also used purified proteins and were unable to
detect an interaction between H-Ras and RGS14 [11]; we are
unable to explain this difference with our present work, although
we note that another group has demonstrated that H-Ras can bind
to RGS14 in vitro [16]. We also note that Traver et al. may have
been using low-sensitivity detection methods, as they were not able
to observe interaction between RGS14 and Gai1/Gai3 [11], the
latter proteins being well-established, nanomolar affinity interac-
tion partners of the RGS14 C-terminal GoLoco motif [14].
Although we did not observe an interaction between RGS14 and
Rap isoforms in cells, we have not definitively ruled out that these
proteins interact in vivo. It may be that post-translational
modification of RGS14 or Rap directly influences Rap/RGS14
interaction or directs these proteins to a distinct subcellular locale
that facilitates their subsequent interaction [50,51]. Our data
demonstrate that RBD1 is the binding site for activated
monomeric GTPases in RGS14. This is concordant with in vitro
and yeast two-hybrid experiments [17,18]. RBD2 within RGS12
appears to be involved in recruiting Raf to form a MAPK
scaffolding complex, as a loss-of-function mutation within RBD1
inhibits the RGS12/H-Ras interaction, but not the RGS12/B-Raf
association [20]. We speculate that RBD2 may possess the same
function within RGS14.
Our observations as to the cellular selectivity of RGS14 are
intriguing, in that we demonstrated that RGS14 can interact with
H-Ras and, to a lesser extent, with N-Ras. Despite extensive studies,
thein vivo mechanisms of Ras-effector GTPaseselectivity arestillnot
fully defined [52]. One contribution to in vivo selectivity is likely
differential subcellular localizations of these GTPases, arising from
Figure 3. Full-length RGS14 interacts with activated H-Ras, but not Rap2A/B, in cells. HEK293T cells were transfected with plasmids
encoding full-length, myc-epitope tagged RGS14, and wild-type (WT) or activated (GV), HA-tagged H-Ras (A), untagged Rap2A (B), or FLAG-tagged
Rap2B (C). Cell lysates were immunoprecipitated (IP) with anti-myc antibodies or precipitated with GST or GST-Raf-1 (as controls). Total lysates and
precipitates were immunoblotted (IB) with indicated antibodies. Data are representative of 3 or more independent experiments.
doi:10.1371/journal.pone.0004884.g003
Figure 4. Full-length RGS14 and H-Ras interact in live cells. HEK293T cells were transfected with the indicated combinations of plasmids,
encoding the N-terminal fragment of Yellow Fluorescent Protein (YFP) fused to the N-terminus of H-Ras(G12S), and the C-terminal fragment of YFP
fused to the C-terminal of full-length Raf-1 or full-length RGS14, respectively. 48 h after transfection cells were analyzed by epifluorescence
microscopy, and fluorescence was quantified using image analysis (as described in Materials and Methods). (A–D) Experiments measuring
fluorescence complementation between H-Ras and Raf-1. (E–H) Experiments measuring fluorescence complementation between H-Ras and RGS14.
Scale bars represent 50 mm. Data are representative of 3 or more independent experiments. Additional control experiments are presented in Figure
S3.
doi:10.1371/journal.pone.0004884.g004
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domain sequences outside the effector domains of Ras family
members. Additionally, regions beyond the RBDs of RGS14, e.g.,
the RGS domain and GoLoco motif, may play a role in the
selectivity of RGS14 for activated H-Ras in cells.
The apparent affinity of activated GTPases for the tandem
RBD region of RGS14 in vitro is weak (e.g., for H-Ras?GPPNHP,
KD=10mM); it is thus most likely that other determinants and
protein partners facilitate the formation of high affinity complexes
in vivo. Despite being unable to observe binary interactions
between RGS14/B-Raf, RGS14/MEK1, or RGS14/ERK1,
RGS14 appears to assemble a stable, multiprotein complex
containing H-Ras, B-Raf, MEK1, and ERK1 when all five
proteins are expressed concomitantly (Figure 5). One report has
asserted that Rap2A is unable to modulate the Ga-directed GAP
or GDI activities of RGS14 in vitro [17]. However, these
experiments were conducted using protein concentrations of
Rap2A and RGS14 that are orders of magnitude below the
determined KD values [17]. Thus it remains to be determined
whether Ras-family GTPase binding to RGS14 can modulate the
GAP and GDI functions of this molecule.
Our present findings with RGS14, in combination with our
previous work on RGS12 [20], support the notion that both RGS
proteins can function to organize multiprotein complexes
containing Ras/Raf/MEK/ERK; however, how these two RGS
proteins achieve this function appears different. Firstly, RGS14
does not appear to bind directly to Raf, MEK, or ERK; in
contrast, RGS12 binds directly to both B-Raf and MEK2 [20].
This distinction most likely arises from the unique domain
architecture of RGS12, which contains two additional domains
(N-terminal PDZ and PTB domains) not present in RGS14. We
established that RGS12 binds to MEK2 via its PDZ domain, and
B-Raf via its tandem RBDs [20]. As RGS14 also contains tandem
RBDs, it is surprising that RGS14 does not bind directly to B-Raf.
Our present data suggest that RGS14 most likely assembles a
MAPK multienzyme complex differently than RGS12. This
highlights the possibility that RGS14 might require additional
protein partners beyond the MAPK members organized in the
complex. Such a requirement for additional accessory proteins
would increase the complexity of possible signaling cascades that
are regulated by RGS14; it is within this scenario that RGS14 may
interact with and modulate Rap-mediated signaling.
Secondly, knockdown of RGS14 in PC12 cells inhibits both
NGF- and bFGF-mediated neuritogenesis, whereas depletion of
RGS12 selectively inhibits only NGF-promoted neuronal differ-
entiation. This selective modulation of growth factor receptor
Figure 5. Full-length RGS14 forms a multiprotein complex with ERK MAPK pathway components dependent on activated H-Ras. (A)
HA-tagged, activated H-Ras(G12V) or R-Ras(G38V) was co-transfected with empty vector, full-length myc-RGS14, or with full-length myc-RGS14 and
FLAG-tagged A-Raf (‘‘A’’), B-Raf (‘‘B’’), or Raf-1 (‘‘1’’) expression vectors in HEK293T cells. Cell lysates were immunoprecipitated (IP) with anti-myc
antibodies. Total lysates and immunoprecipitates were immunoblotted (IB) with indicated antibodies. (B) HEK293T cells were transfected with
plasmids encoding full-length myc-RGS14, HA-H-Ras(G12V), HA-B-Raf, HA-MEK1, and HA-ERK1 in various combinations as indicated. Cell lysates were
immunoprecipitated (IP) with anti-myc antibodies. Total lysates and immunoprecipitates were immunoblotted (IB) with indicated antibodies. Data
are representative of 3 or more independent experiments.
doi:10.1371/journal.pone.0004884.g005
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bind to the NGF receptor TrkA, but not to FGFR1 [20]. While we
have shown that (a) RGS12 associates with TrkA, (b) RGS12
undergoes subcellular redistribution in response to NGF stimula-
tion, and (c) RGS12 is localized coincident with endosomal
markers in cells, we presently have no evidence for any of these
functions or behaviors for RGS14. In contrast, RGS14 is typically
localized to the cytosol, nucleus, and perinuclear regions in
interphase, and on microtubule structures during mitosis [53–55].
Thus, coordinating activated Ras and the MAPK cascade at
subcellular locales distinct from RGS12 likely engenders a
different set of outputs (i.e., distinct ERK phosphorylation
substrates) from RGS14-dependent signaling; independent MAPK
signaling dependent on RGS14 that is equally critical for an
integrated, long-term phenotypic response to a growth factor like
NGF would explain why RGS12 is not able to compensate for the
loss of RGS14 in NGF-induced neuritogenesis in siRNA-treated
PC12 cells.
It is important to note also that RGS14 has biochemical
properties atypical of a classical MAPK scaffold such as RGS12,
MP1, STE5, and others. We were unable to detect binary
interaction of RGS14 with any MAPK pathway members other
than Ras. Typical MAPK scaffolds demonstrate binary interac-
tions with multiple MAPK components. It is possible that H-Ras
binding induces a conformational change in RGS14 that facilitates
binding to additional MAPK pathway members, or that
interaction with MAPK members is activation-dependent. Cellu-
lar evidence for a MAPK scaffolding-like function for RGS14 is
provided by the requirement of RGS14 expression for B-
Raf(V600E)-induced signal transduction in PC12 cells (Figure 7).
We have not yet delineated the structural determinants of
multiprotein-complex formation between Ras, RGS14, and Raf.
We hypothesize that this interaction is unlikely due to simulta-
neous binding of RGS14 and Raf to activated H-Ras. Both RBD1
of RGS14 and the sole RBD of Raf proteins represent
evolutionarily conserved binding sites for the effector loops (switch
regions) of activated Ras-family GTPases [16,56]. Thus, based on
the current structural knowledge, simultaneous binding of a single
molecule of activated H-Ras to two RBDs is highly improbable.
Evidence supporting the alternative view of Ras/RGS14/Raf
complex formation is illustrated in Figure 5A, as formation of this
complex is Raf-isoform selective. In the absence of RGS14, H-
Ras(G12V) interacts equivalently with Raf-1, A-Raf, and B-Raf
(data not shown). However, in the presence of RGS14, complex
formation showed distinct selectivity towards B-Raf and Raf-1, but
not A-Raf, in terms of the amount of H-Ras(G12V) co-
precipitated. This suggests that facile co-precipitation of Ras in
binary complexes with RGS14 and with Raf is not occurring and
that a Raf-isoform selective phenomenon is being observed.
In conclusion, our studies delineate a potential major difference
between the physiological roles of RGS12 and RGS14. Conven-
tional MAPK scaffold proteins execute two main functions: (i)
tethering proteins together, and (ii) specifying the subcellular
localization of the multiprotein complex which, in turn, guides
their final output. The finding that RGS12 is localized to
endocytic vesicles and acts as a conventional MAPK scaffold that
regulates NGF-promoted signaling in both PC12 and DRG
neurons [20] supports the notion that RGS12 and its partners are
key components of ‘signaling endosomes’ that form in the axon
terminal and traffic in a retrograde manner to the cell body where
Figure 6. RGS14 knockdown inhibits NGF- and bFGF-induced neurite outgrowth. PC12 cells were transfected with a control non-specific
(NS) siRNA or four independent RGS14 siRNA duplexes (#1-4). Twenty four hours later, cells were treated with 100 ng/ml NGF (A) or 100 ng/ml bFGF
(B). Forty eight hours after growth factor treatment, neurite outgrowth was visualized by phase contrast microscopy and digital image capture.
Representative images are presented to illustrate the effect of non-specific versus RGS14 duplex-2 siRNA on neurite outgrowth (right panels). The
length of .100 neurites per condition was quantifed using ImageJ. Data are plotted as dot plots with the mean of each condition represented by a
black line. Statistical significance was assessed by Kruskal-Wallis test with Dunn’s post test. For both NGF- and bFGF-stimulated neurite outgrowth,
statistical significance (P,0.001) was obtained for NS versus siRNA duplexes #1, #2, #3, and #4. Data are representative of 3 or more independent
experiments.
doi:10.1371/journal.pone.0004884.g006
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subcellular localization of RGS14 is distinct from that of RGS12,
and this may be reflective of functional differences in the ability to
modulate signal transduction, such as the ability of RGS14, but
not RGS12, to modulate FGFR-mediated signal transduction.
Thus, it is likely that, in vivo, RGS14 integrates signaling
independent of, and with different consequences than, RGS12.
Supporting Information
Figure S1 Guanine nucleotide-state selective interaction between
H-Ras and RGS14. Isothermal titration calorimetry was used to
measure the interaction between H Ras and the isolated Ras-
binding domains of RGS14 (‘‘RGS14(RBD1.RBD2)’’). A stepwise
titration of 300 mM RGS14(RBD1.RBD2) protein into a cell
containing 20 mM H Ras(GPPNHP) (A) or H-Ras(GDP) (B) was
performed and the heat change accompanying RGS14 injection
was detected by comparison with a reference cell.
RGS14(RBD1.RBD2) injected into buffer alone was used as a
negative control. Heat changes were plotted against the molar ratio
of H Ras to RGS14(RBD1.RBD2) protein and analyzed using non-
linear regression (see Table 1 of the main manuscript for data
analysis parameters). Data was fit by applying a one-site binding
model involving exothermic reaction phases (negative enthalpy
changes) with favorable free energy changes. Analysis of the data
indicatesthat complete saturation ofthebindingsite is notachieved.
This is likely due to the high dissociation rate of the complex.
Found at: doi:10.1371/journal.pone.0004884.s001 (0.66 MB TIF)
Figure S2 RGS14 selectively interacts with H-Ras and not other
small GTPases in cells. HEK293T cells were transfected with
plasmids encoding full-length myc-RGS14 and various mutation-
ally-activated (‘‘GV’’, ‘‘GD’’, or ‘‘QL’’), HA-epitope tagged
GTPases. Cell lysates were immunoprecipitated (IP) with anti-
myc antibodies. Total lysates and precipitates were immuno-
blotted (IB) with indicated antibodies. ‘‘Arf GTPase’’ denotes the
use of Arf1.
Found at: doi:10.1371/journal.pone.0004884.s002 (3.18 MB TIF)
Figure S3 Specificity of fluorescence complementation between
H-Ras(G12S) and RGS14. HEK293T cells were co-transfected
with cDNAs encoding the empty vector pcDNA3.1, the N-
terminal (amino acids 1–159) and C-terminal (amino acids 159-
239) fragments of Yellow Fluorescent Protein (YFPN and YFPC),
and indicated proteins fused to YFPN and YFPC. 48 hours after
transfection, cells were analyzed by epifluorescence microscopy,
and fluorescence was quantified using image analysis as described
in the Experimental section. (A) Transfection of the YFPC vector
or YFPC-fusion constructs does not result in measurable
fluorescence in the absence of YFPN co-transfection. (B) YFPN
alone does not complement YFPC nor YFPC-fusion constructs.
(C) YFPN-H-Ras(G12S) complements both RGS14-YFPC and
Raf-1-YFPC but not YFPC nor YFPC-Gb1. (D) YFPN-Gc2
complements YFPC-Gb1 but not YFPC, RGS14-YFPC, nor Raf-
1-YFPC.
Figure 7. RGS14 knockdown inhibits activated H-Ras- and activated B-Raf-induced neurite outgrowth. PC12 cells were co-transfected
with expression vectors for constitutively-activated H-Ras(G12V) (A, B) or B-Raf(V600E) (C, D) with either a non-specific (NS) siRNA duplex or one of
four independent RGS14 siRNA duplexes (#1-4). Cells left untransfected are denoted control (CTRL). Seventy-two hours after transfection, neurite
outgrowth was visualized by phase contrast microscopy and digital image capture. The length of .82 neurites per condition was quantifed using
ImageJ. Data are plotted as dot plots with the mean of each condition represented by a black line (A, C). Significance was assessed by Kruskal-Wallis
test with Dunn’s post test. For both B-Raf(V600E)- and H-Ras(G12V)-stimulated neurite outgrowth, P,0.001 for NS versus #1, #2, #3, and #4. (B, D)
The percentage of cells with neurites longer than one cell body length was measured for the experiments presented in panels A and C. Data are
representative of 3 or more independent experiments.
doi:10.1371/journal.pone.0004884.g007
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PLoS ONE | www.plosone.org 11 March 2009 | Volume 4 | Issue 3 | e4884Found at: doi:10.1371/journal.pone.0004884.s003 (0.86 MB TIF)
Figure S4 Specificity of H-Ras/RGS14/B-Raf complex forma-
tion. HEK293T cells were transfected with plasmids encoding full-
length myc-RGS14, HA-B-Raf, and either wild-type or G12V
HA-H-Ras. Cell lysates were immunoprecipitated (IP) with anti-
myc antibodies and protein A/G agarose, as indicated. Total
lysates and immunoprecipitates were immunoblotted (IB) with
indicated antibodies.
Found at: doi:10.1371/journal.pone.0004884.s004 (3.08 MB TIF)
Figure S5 Specificity and efficacy of rat RGS14 siRNAs (I). (A)
HEK293T cells were transfected with HA-epitope tagged RGS14
expression vector and then 6 hours later transfected with control
non-specific (NS) siRNA or a pool of four RGS14 siRNAs. 24, 48,
and 72 hours later, RGS14 expression level was analyzed by
immunoblot (IB) with anti-HA. Samples were immunoblotted with
anti-actin antibodies as a control for total protein levels. (B)
HEK293T cells were transfected with myc-epitope tagged RGS14
expression vector and then 6 hours later transfected with control
non-specific (NS) siRNA or four independent RGS14 siRNA
duplexes (#1-4) that constitute the siRNA SMARTpool used in
panel A. 48 hours later RGS14 expression level was analyzed by
immunoblot with anti-myc antibodies. Samples were immuno-
blotted with anti-actin antibodies as a controlfor total protein levels.
Found at: doi:10.1371/journal.pone.0004884.s005 (1.89 MB TIF)
Figure S6 Specificity and efficacy of rat RGS12 and RGS14
siRNAs (II). PC-12 cells were transfected with control non-specific
(NS) siRNA, RGS12(D2) siRNA (duplex 2 from ref. 20), a
SMARTpool (SP) of four RGS14 siRNA duplexes, or the four
individual constituent siRNA duplexes (D1, D2, D3, and D4)
which comprise the SMARTpool. Forty eight hours later, cells
were harvested, RNA was extracted, and RGS12 (A) and RGS14
(B) expression levels were measured by quantitative real-time PCR
(as performed by the Gene Expression Core of the UNC Dept. of
Laboratory Medicine and Pathology, directed by Dr. Hyung-Suk
Kim). RGS12 and RGS14 data were normalized for relative
expression levels using the 2-(,delta.,delta.Ct) method with b-
actin as the internal control. Data is presented as relative
expression compared to non-specific (NS) siRNA treated samples.
Statistical significance was determined using ANOVA with
Dunnett’s multiple comparison test (* denotes P,0.5 vs NS
siRNA samples).
Found at: doi:10.1371/journal.pone.0004884.s006 (0.30 MB TIF)
Figure S7 Yeast two-hybrid analysis of interactions between
RGS14 and Ras-family GTPases. Yeast were co-transformed with
bait plasmids encoding indicated GTPase fusions with the Gal4p
DNA binding domain and prey plasmids encoding either Raf-1 or
RGS14 fused to the Gal4p activation domain. Wild-type (WT) or
glycine-12-to-valine (GV) mutationally-activated GTPases were
used to test for activation-dependent binding to the Ras-binding
domain (RBD) of Raf-1 (amino acids 50–131) and the tandem
RBDs and GoLoco motif of RGS14 (amino acids 263–544). Yeast
were plated on synthetic defined agar (SDA), lacking leucine (-Leu,
to select for the pACT-II plasmid containing the LEU2 gene), and
tryptophan (-Trp, to select for the pGBT9 plasmid containing the
TRP1 gene). Growth on SDA-Leu-Trp demonstrates incorpora-
tion of bait and prey plasmids (top panel). Growth on SDA-Leu-
Trp-His in the presence of the histidine biosynthesis inhibitor 3-
amino-1,2,4-triazole (3AT) indicates a positive protein-protein
interaction.
Found at: doi:10.1371/journal.pone.0004884.s007 (2.04 MB TIF)
Table S1 DNA constructs created and obtained for use in this
study.
Found at: doi:10.1371/journal.pone.0004884.s008 (0.10 MB
PDF)
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